SCHEMBL5779882

SCHEMBL5779882

O=C1C[C@H](CO)C(=O)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2915829 1.00 — —
SCHEMBL19839455 1.00 — —
SCHEMBL1536267 0.84 MAP3K14 (0.43) —
SCHEMBL28479332 0.82 MAP3K14 (0.50) —
SCHEMBL17907172 0.80 MAP3K14 (0.48) —
SCHEMBL29129779 0.78 MAP3K14 (0.46) —
SCHEMBL10573688 0.78 — —
SCHEMBL6525084 0.77 HLCS (0.38) —
SCHEMBL11274777 0.76 MAP3K14 (0.44) —
SCHEMBL18909611 0.76 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3494106-A1 PROCESSES FOR MAKING, AND METHODS OF USING, GLYCOPYRRONIUM COMPOUNDS Dermira, Inc. (US) 2019-06-12 — — EP disclosed
WO-2018026869-A1 PROCESSES FOR MAKING, AND METHODS OF USING, GLYCOPYRRONIUM COMPOUNDS DERMIRA, INC. (US) 2018-02-08 — — WO disclosed
EP-1706384-A1 THERAPEUTIC AGENTS I AstraZeneca AB (SE) 2006-10-04 — — EP disclosed
WO-2005066132-A1 THERAPEUTIC AGENTS I ASTRAZENECA AB (SE) 2005-07-21 — — WO disclosed
Send feedback